MEDIOMICS LLC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are DONGFANG HEPATOBILLIARY HOSPITAL AFFILIATED TO THE SECOND MILITARY MEDICAL UNIVERSITY, CHROMAXOME CORP and BASE PAIR BIOTECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | United States | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | India | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Tian Ling | 9 |
#2 | Chang Yie-Hwa | 7 |
#3 | Waisman David | 4 |
#4 | Wang Rongsheng | 4 |
#5 | Tricomi Sally | 3 |
#6 | Heyduk Tomasz | 2 |
#7 | Kwon Mijung | 1 |
#8 | Chang Yie Hwa | 1 |
Publication | Filing date | Title |
---|---|---|
US2016077088A1 | Molecular biosensors with a modular design | |
CN103842521A | Compositions and methods for selecting aptamers | |
EP1581164A2 | Compositions and methods for inhibiting tumor growth and metastasis | |
AU2002357017A1 | Anti-angiogenesis methods, compositions and uses therefor |